AXIM Biotechnologies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of AXIM Biotechnologies generated cash of -$1,030,500, which is more than the previous year. Cash used in financing activities reached the amount of $1,139,675 last year. Net change in cash is therefore $109,175.
Cash Flow
| 2014 | -338.99K | 0 | 1M |
|---|---|---|---|
| 2015 | -1.53M | -16.78K | 1.02M |
| 2016 | -1.29M | 0 | 1.87M |
| 2017 | -3.08M | 0 | 4.42M |
| 2018 | -4.84M | 0 | 4.59M |
| 2019 | -5.02M | 348.18K | 3.37M |
| 2020 | -3.21M | 9.98K | 3.15M |
| 2021 | -2.48M | -50.49K | 2.53M |
| 2022 | -2.04M | -8.71K | 1.64M |
| 2023 | -1.03M | 0 | 1.13M |
AXIM Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 47.28K | 452.96K | 457.18K | 511.63K | 1.80M | 2.05M | 713.34K | 134.17K | 661.12K | 127 |
Operating activities | ||||||||||
Net income | -8.05M | -6.24M | -16.03M | -6.40M | -6.44M | -6.75M | -4.16M | -5.80M | -10.09M | -582.94K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 427.01K | 426.12K | 2.11M | 16.00K | 6.51K | 12.83K | 3.35K | 3.35K | 1.11K | 0 |
Stock-based compensation expense | 197.72K | 1.10M | 1.14M | 2.31M | 1.83M | 0 | 55.8K | 1.44M | 5.97M | 0 |
| Deferred income tax benefit | 197.72K | 1.10M | 1.14M | 2.31M | 1.83M | 0 | 55.8K | 1.44M | 5.97M | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 1.70K | -1.02K | -675 | -315.84K | 0 | 173.84K | 0 | 0 | -4K |
Inventories | 0 | 20.08K | -20.08K | 675 | -478.01K | -1.03K | 29.68K | 152.58K | 46.20K | 0 |
Accounts payable | 769.03K | 659.4K | 277.50B | 532.24K | 673.52K | -116.33K | 40.53K | 188.91K | 248.55K | 145.78K |
Cash generated by operating activities | -1.03M | -2.04M | -2.48M | -3.21M | -5.02M | -4.84M | -3.08M | -1.29M | -1.53M | -338.99K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -8.71K | -50.49K | -97.32K | 0 | 0 | 0 | 0 | -16.78K | 0 |
Acquisitions Net | 0 | 0 | 0 | 79.81K | -27.49K | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | -8.71K | -50.49K | 9.98K | 348.18K | 0 | 0 | 0 | -16.78K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 491.45K | 1.74M | 1.63M | 3.30M | 3.46M | 4.36M | 115K | 115K | 20K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | -1.47M | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 25B | 0 | 0 | 600K | 5.3M | 0 | 0 | 0 |
Repayments of term debt | 675K | -8.2K | -120K | -92.86K | 11.34K | -1.96M | 3.92M | -124.84K | 0 | 0 |
Cash used in financing activities | 1.13M | 1.64M | 2.53M | 3.15M | 3.37M | 4.59M | 4.42M | 1.87M | 1.02M | 1M |
Net Change In Cash | 109.17K | -405.68K | -4.21K | -54.44K | -1.29M | -252.21K | 1.34M | 579.17K | -526.95K | 661.00K |
Cash at end of period | 156.45K | 47.28K | 452.96K | 457.18K | 511.63K | 1.80M | 2.05M | 713.34K | 134.17K | 661.12K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |